Genocea to Present at 2016 BIO CEO & Investor Conference
Feb 01, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 01, 2016 -- Genocea Biosciences, Inc.(NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Chip Clark, president and chief...
Feb 01, 2016 13:00 pm UTC| Business
4th vs. 3rd Quarter 2015 Highlights: Earnings of $32.0 million, or $.27 per common shareOrganic loan growth of $102.0 million, or 6.0% annualized, excluding covered loans5.3% decline in operational noninterest...
Intra-Cellular Therapies to Present at the Leerink Partners’ 5th Annual Global Healthcare Conference
Feb 01, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 01, 2016 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today announced that Sharon...
Feb 01, 2016 13:00 pm UTC| Business
BILLERICA, Mass., Feb. 01, 2016 -- American Science and Engineering, Inc. (“ASE”) (NASDAQ:ASEI) will announce its third quarter (ended December 31, 2015) fiscal year 2016 results on Monday, February 8, 2016 after the...
Oryzon Receives Approval in Spain to Initiate Phase I for ORY-2001 for Alzheimer’s Disease
Feb 01, 2016 13:00 pm UTC| Business
BARCELONA, Spain and CAMBRIDGE, Mass., Feb. 01, 2016 -- Oryzon Genomics (ISIN Code: ES0167733015), a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative...
PacWest Bancorp Announces Quarterly Dividend
Feb 01, 2016 13:00 pm UTC| Business
LOS ANGELES, Feb. 01, 2016 -- PacWest Bancorp (Nasdaq:PACW) announced today that its Board of Directors has declared a quarterly cash dividend of $0.50 per common share. The cash dividend is payable on February 29, 2016...
Catalyst Biosciences to Present at 18th Annual BIO CEO & Investor Conference
Feb 01, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2016 -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on creating and developing novel medicines in the fields of hemostasis and...